Applied Evidence

How to assess and relieve that perplexing rashless itch

Author and Disclosure Information

 

References

When a patient complains of severe pruritus at first presentation, consider pharmacotherapy in conjunction with nonpharmacotherapeutic options. Several of the more effective topical therapies for pruritusa are listed in TABLE 4.20 Well-known systemic agents for this purpose are reviewed below and listed in TABLE 5.7

Topical therapies for pruritus without skin lesions

Systemic treatment

Antihistamines. A staple in the treatment of pruritus for many years, antihistamines are not effective for all causes; however, they are effective in treating paraneoplastic pruritus.20 First-generation antihistamines, with their sedating effect, can be useful for patients who experience generalized pruritus at night.20

Systemic therapies for pruritus without skin lesions

Anticonvulsants. Gabapentin and pregabalin are analogs of the neurotransmitter gamma-aminobutyric acid.20 This drug class is helpful in neuropathic pruritus specifically caused by impingements, such as brachioradial pruritus and notalgia paresthetica.20 In addition, of all systemic therapies used to treat uremic pruritus, gabapentin has, in clinical trials, most consistently been found effective for uremic pruritus.6 (Note: Use renal dosing of gabapentin in patients with renal failure.)

Antidepressants. Selective serotonin reuptake inhibitors (SSRIs; eg, fluvoxamine, paroxetine, and sertraline) might cause itch to subside by increasing the serotonin level, which, in turn, works to decrease inflammatory substances that cause itch.7 SSRIs have been used to treat patients with psychogenic pruritus, cholestatic pruritus, and paraneoplastic pruritus.7

Start conservatively: Use behavior modification and nonpharmacotherapeutic options for pruritus first.

Tricyclic antidepressants (eg, amitriptyline and doxepin) lessen the itch by antagonizing histamine receptors and through anticholinergic mechanisms. Tricyclics are best used in the treatment of psychogenic and nocturnal itch.7

Continue to: Mirtazapine...

Pages

Recommended Reading

Stroke may be the first symptom of COVID-19 in younger patients
MDedge Family Medicine
COVID-19 risks are no higher in patients with multiple sclerosis
MDedge Family Medicine
28-year-old woman • weakness • anxiety • altered mental status • Dx?
MDedge Family Medicine
Migraine nerve stimulation device now available over the counter
MDedge Family Medicine
HIT-6 may help track meaningful change in chronic migraine
MDedge Family Medicine
Worldwide measles vaccination is flagging
MDedge Family Medicine
COVID-19 diagnosed on CTA scan in stroke patients
MDedge Family Medicine
A skin test for Parkinson’s disease diagnosis?
MDedge Family Medicine
Blood test for Alzheimer’s disease comes to the clinic
MDedge Family Medicine
Increasing ear pain and headache
MDedge Family Medicine